Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.790
-0.090 (-1.84%)
May 30, 2025, 2:24 PM - Market open
Radiopharm Theranostics Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Radiopharm Theranostics stock ranges from a low of $12 to a high of $15. The average analyst price target of $13.5 forecasts a 181.84% increase in the stock price over the next year.
Price Target: $13.50 (+181.84%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Radiopharm Theranostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 |
---|---|---|---|
Strong Buy | 1 | 1 | 2 |
Buy | 0 | 0 | 0 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +150.52% | May 1, 2025 |
B. Riley Securities | B. Riley Securities | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +213.15% | Mar 12, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.96M
Revenue Next Year
45.25M
EPS This Year
-0.03
from -0.12
EPS Next Year
-0.22
from -0.03
Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | n/a | 47.0M | 54.5M | |||
Avg | n/a | 45.2M | 52.4M | |||
Low | n/a | 43.9M | 50.9M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | - | - | 20.4% | |||
Avg | - | - | 15.8% | |||
Low | - | - | 12.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | -0.02 | -0.02 | - | |||
Avg | -0.03 | -0.22 | -0.30 | |||
Low | -0.03 | -0.59 | -0.59 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.